EditorialA poster of the geneticist Dr. Terry Jackson as a child with sickle cell anemia, in his office in Petersburg, Va., Dec. 19, 2022. (Carlos Bernate/The New York Times)
EditorialCanadian geneticist Cassandra Extavour in her office at Harvard University, in Cambridge, Mass., on July 25, 2022. (Tony Luong/The New York Times)
EditorialCanadian geneticist Cassandra Extavour in her office at Harvard University, in Cambridge, Mass., on July 25, 2022. (Tony Luong/The New York Times)
EditorialKristin Brzeski, a conservation geneticist who was a postdoctoral fellow in Bridgett vonHoldt’s lab, in Galveston, Texas, Aug. 18, 2021. (Tristan Spinski/The New York Times)
EditorialA technician drills into a skull to retrieve DNA, at the Harvard geneticist David Reich?s lab in Boston, March 15, 2018. (Kayana Szymczak/The New York Times)
EditorialHeidi Marsh with a genealogy chart to track the PALB2 mutation for Dr. Marc Tischkowitz, a geneticist at the University of Cambridge and creator of the PALB2 Interest Group, who is conducting a study on the mutation, in Mulkiteo, Wash., Aug. 3, 2021. (Jovelle Tamayo/The New York Times)
EditorialPardis Sabeti, a geneticist at the Broad Institute of M.I.T. and Harvard, in Cambridge, Mass., Nov. 26, 2014. (Damon Winter/The New York Times)
EditorialTulio de Oliveira, a geneticist at the Nelson Mandela School of Medicine, collects COVID-19 samples from a hospital in Durban, South Africa, Jan. 8, 2021. (Joao Silva/The New York Times)
EditorialProf. Tulio de Oliveira, a geneticist, at work in his lab at the Nelson Mandela School of Medicine in Durban, South Africa, on Friday, Jan. 8, 2021. (Joao Silva/The New York Times)
EditorialDr. Lindsey Robinson-McCarthy, a geneticist at Harvard University, on the school’s campus in Boston, Nov. 11, 2020. (Adam Glanzman/The New York Times)
EditorialDr. Ravi Savarirayan, a clinical geneticist who led a trial of the drug vosoritide, in Melbourne, Australia, Sept. 5, 2020. (Christina Simons/The New York Times)